23 Miss. Code. R. 214-1.10 - Preferred Drug List
A. The Division of
Medicaid recommends that prescribers use the drugs on the Preferred Drug List
(PDL).
1. The PDL is defined as a list of
drugs reviewed and proposed by the Pharmacy and Therapeutics (P&T)
Committee, a group of physicians, pharmacists, nurse practitioners, and/or
other health care professionals. Final approval of the PDL is the
responsibility of the Executive Director of the Division of Medicaid.
2. The PDL contains a wide range of generic
and preferred brand name products approved by the FDA.
3. A medication becomes a preferred drug
based first on safety and efficacy, then on cost-effectiveness.
B. Prior authorizations for
non-preferred drugs may be approved for medically accepted indications when
criteria have been met.
C. Drugs
must be prescribed and dispensed in accordance with medically accepted
indications for uses and dosages. No payment will be made under the Medicaid
program for services, procedures, supplies or drugs still in clinical trials
and/or investigative or experimental in nature.
D. Prior authorizations are reviewed and a
determination notice provided within twenty-four (24) hours from receipt of
request. If a PA is not available, a seventy-two (72) hour emergency supply
must be dispensed. Pharmacists should use his/her professional judgment
regarding whether or not there is an immediate need every time the seventy-two
(72) hour option is used. The seventy-two (72) hour emergency procedure must
not be used for routine and continuous overrides.
E. The PDL is subject to change. [Refer to
the Division of Medicaid's website for a current listing of prescription drugs
on the PDL.]
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.